They've made it tough by choosing to start human trials targeting a type of cancer that affects only a very small pool of people. I don't know if they realised how difficult it would be to fulfill their enrollment targets. In saying all that we aren't certain how the enrollment is progressing and it may be going better than is speculated here.
Interesting, page-3960
-
- There are more pages in this discussion • 1,547 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
